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Novel insights into the metabolic alterations of critical
illness, including new findings on association between
blood glucose at admission and poor outcome, were
published in Critical Care in 2013. The role of diabetic
status in the relation of the three domains of glycemic
control (hyperglycemia, hypoglycemia, and glycemic
variability) was clarified: the association between mean
glucose, high glucose variability, and ICU mortality
was stronger in the non-diabetic than in diabetic
patients. Improvements in the understanding of
pathophysiological mechanisms of stress hyperglycemia
were presented. Novel developments for the
management of glucose control included automated
closed-loop algorithms based on subcutaneous glucose
measurements and microdialysis techniques. In the field
of obesity, some new hypotheses that could explain the
‘obesity paradox’ were released, and a role of adipose
tissue in the response to stress was suggested by the
time course of adipocyte fatty-acid binding protein
concentrations. In the field of nutrition, beneficial
immunological effects have been associated with early
enteral nutrition. Early enteral nutrition was significantly
associated with potential beneficial effects on the
phenotype of lymphocytes. Uncertainties regarding the
potential benefits of small intestine feeding compared
with gastric feeding were further investigated. No
significant differences were observed between the
nasogastric and nasojejunal feeding groups in the
incidence of mortality, tracheal aspiration, or
exacerbation of pain. The major risk factors to develop
diarrhea in the ICU were described. Finally, the
understanding of disorders associated with trauma and
potential benefits of blood acidification was improved
by new experimental findings.* Correspondence: jean-charles.preiser@erasme.ulb.ac.be
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In Critical Care in 2013, several important contributions
in the fields of physiology and clinical management of
glucose control, enteral nutrition, and gastrointestinal
disorders; specificity of critically ill obese patients; and
critical illness-related endocrine alterations were pub-
lished. These articles can be gathered into four areas of
interest.Glucose metabolism and control
The management of stress-related hyperglycemia has been
the focus of several prospective studies that yielded results
still fueling a hot debate [1,2]. The concept of the three
domains of dysglycemia (hyperglycemia, hypoglycemia,
and glycemic variability) has emerged over the last year.
Indeed, all three domains have been independently associ-
ated with increased risk of mortality in ICU patients [3,4].
Analysis of the results showed that hypoglycemia had the
strongest association with mortality and that the negative
effects of hyperglycemia and greater glycemic variability
were additive. Nowadays, the magnitude of stress-related
hyperglycemia can be considered a surrogate marker of
the severity of disease. Hence, an optimal target of glucose
control is probably elusive, and the quality of glucose
control should rather be considered a quality indicator of
critical care service. Those findings fostered research in
several different fields. Epidemiological insights included
association studies between blood glucose (BG) and out-
come, endocrine pathways were investigated as potential
contributors of stress hyperglycemia, and computer-
assisted decision systems and continuous glucose moni-
toring were assessed in clinical conditions.Association between blood glucose levels and outcome
Recently, admission BG level was demonstrated as an inde-
pendent predictor of mortality in patients with ST-segment
elevation myocardial infarction (STEMI) regardless of the
diabetic status [5]. Between November 2005 and September
2010, 816 STEMI patients with cardiogenic shock were
enrolled in a prospective multicenter Korean study that in-
vestigated the impact of admission BG on 30-day mortality
[6]. The 30-day mortality rates were higher in patients withCentral Ltd. The licensee has exclusive rights to distribute this article, in any
ion. After this time, the article is available under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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patients, suggesting that the toxic effect of hyperglycemia
may be limited in patients with known diabetes mellitus
(DM).
The influence of pre-existing DM on the relation of
these three domains of glycemic control with mortality
remained uncertain. A new study examining markers of
glycemic control in a DM cohort and a non-DM cohort
simultaneously was published last year [7]. This single-
center retrospective study performed on a cohort of more
than 10,320 patients (of whom 16% had DM) reported a
strong association between mean glucose and high glucose
variability and ICU mortality in the non-DM cohort only.
Hypoglycemia (≤2.2 mmol/L) was associated with ICU
mortality in both cohorts. Secondly, a higher threshold for
toxicity was found in the non-DM cohort (4.9 mmol/L)
than in the DM cohort (3.5 mmol/L), suggesting once
again that DM patients may tolerate a wider glucose
range. This could be explained by the fact that patients
with DM may develop a cellular adaption over time as the
reduction of mitochondrial-derived reactive oxygen
species and therefore better tolerate episodes of hypergly-
cemia in an acute care setting [8,9].
Physiopathology of stress hyperglycemia
The metabolic response to stress is part of the adaptive
response to survive critical illness. It involves a subse-
quent neuroendocrine and an immune component lead-
ing to an uncontrolled catabolism, the development of
resistance to anabolic signals (including insulin), and an
inability to suppress the central hepatic glucose produc-
tion [10]. Many acute metabolic changes seen in critic-
ally ill patients are similar to those seen in patients with
metabolic syndrome. Similar changes can be involved in
the acute stress responses associated with critical illness
[11]. Adipocyte fatty-acid binding protein (A-FABP) is
one of the most abundant intracellular lipid transport
proteins in mature adipocytes and macrophages. Recent
studies have confirmed its role in various conditions as-
sociated with insulin resistance, including metabolic
syndrome [12,13]. More than 100 patients admitted to a
medical ICU were prospectively enrolled in a study
whose purpose was to determine the correlation be-
tween A-FABP, systemic inflammation, and insulin re-
sistance associated with critical illness [14]. Blood
samples were collected within 48 hours of ICU admis-
sion. Elevated A-FABP concentrations in patients with
critical illness were positively correlated with Acute
Physiology and Chronic Health Evaluation II (APACHE
II) scores, inflammatory cytokine tumor necrosis factor-
alpha, and insulin resistance. The A-FABP concentra-
tions were not associated with pre-existing DM and
body mass index (BMI), suggesting that circulating A-
FABP reflects critical illness-related insulin resistance.This major finding suggests a major role for the adipose
in the response to stress.
Clinical management of glucose control
Accurate measurements are critical for treatment deci-
sions. Actually, repeated blood gas analyses represent
the best option to measure BG within the ICU [15]. A
systematic review assessed the accuracy of BG measure-
ments in the ICU by using different techniques (by glu-
cose meters and arterial blood gas analyzers) with
central laboratory methods as references [16]. Results of
the study showed a significantly higher accuracy of BG
measurements with arterial gas analyzers than measure-
ments with glucose meters. These data also suggest that
arterial blood samples rather than capillary blood sam-
ples should be used and certainly in patients with
unstable hemodynamics or receiving insulin infusion or
both. Otherwise, BG measurements in the hypoglycemic
range were less accurate than those in the non-
hypoglycemic range in all devices.
New technologies could improve the management of
BG and help to prevent the three domains of dysglycemia.
Over the last decade, continuous subcutaneous glucose
monitoring has emerged as a valuable tool in the manage-
ment of diabetes [17]. A pilot preliminary randomized
controlled single-center trial evaluated the feasibility of
automated closed-loop glucose control based on subcuta-
neous glucose measurements in critically ill adults [18].
Twenty-four patients hospitalized in a neurologic ICU
with hyperglycemia (≥10 mM) or already receiving insulin
therapy were randomly assigned to receive one of the fol-
lowing over a 48-hour period: fully automated closed-loop
therapy (model predictive control algorithm directing insu-
lin and 20% dextrose infusion based on FreeStyle Navigator
(Abbott Laboratories, Abbott Park, IL, USA) continuous
subcutaneous glucose values, n =12) or a local protocol
(moderate glucose target of 6.0 to 8.0 mmol/L, n =12) with
intravenous sliding-scale insulin. The primary endpoint was
percentage of time when arterial blood glucose was be-
tween 6.0 and 8.0 mmol/L. The proportion of time in target
range was significantly increased during closed-loop ther-
apy (54.3% versus 18.5%, P =0.001). Mean glucose was sig-
nificantly lower during closed-loop without hypoglycemia
(<4 mmol/L) during either therapy. No adverse event linked
to the sensor was recorded. These results suggested that
fully automated closed-loop control based on subcutaneous
glucose measurements might provide safe, effective, and
consistent glucose control without increasing the risk of
hypoglycemia.
A pilot observational prospective study tested a central
vein catheter with a microdialysis membrane in combin-
ation with an on-line analyzer for continuous monitoring of
circulating glucose and lactate by the central route [19].
Ten patients scheduled for major upper abdominal surgery
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(Eirus SLC, Dipylon Medical AB, Solna, Sweden). Continu-
ous microdialysis measurement proceeded for 20 hours,
and on-line values were collected every minute. Reference
arterial plasma glucose and blood lactate samples were col-
lected every hour. Results showed a close agreement be-
tween the continuous reading and the reference BG values
and a high correlation to plasma readings (r =0.92). The
intravascular microdialysis technique using central venous
access shows promising results compared with reference
plasma values, justifying further testing, especially in ICU
patients.
Outcome of obese patients with sepsis
Obesity is an increasingly prevalent comorbidity in critically
ill patients. Despite the apparent risk factors associated with
obesity, several studies suggested better outcome for obese
than non-obese patients [20]. This phenomenon has been
named the ‘obesity paradox’. Several studies focused on the
subject last year.
Firstly, a retrospective analysis compared three groups
of septic shock patients on the basis of the BMI in pa-
tients enrolled in the VASST (Vasopressin and Septic
Shock Trial) (n =778 patients) cohort [21]. Obese (BMI
of greater than 30 kg/m2, n =245) and overweight (BMI
of 25.0 to 29.9 kg/m2, n =276) patients with septic shock
had significantly lower 28-day mortality and less organ dys-
function than patients with a BMI of less than 25 kg/m2,
despite similar severity at presentation. Compared with the
patients with a BMI of less than 25 kg/m2, obese and over-
weight patients also had a different pattern of infection with
less lung and fungal infection. Per kilogram, obese and
overweight patients received less fluid and less norepineph-
rine or vasopressin compared with patients with a BMI of
less than 25 kg/m2. Obese and overweight patients also had
lower plasma interleukin-6 concentration at baseline. How-
ever, the reason why these patients present an altered in-
flammatory response is still unknown.
Secondly, a nested cohort study (n =2,882) within a
multicenter retrospective database of patients with sep-
tic shock has been published [22]. Very obese patients
more frequently developed skin and soft tissue infec-
tions and were less likely to have pneumonia. Obese and
very obese patients were more likely to have Gram-
positive infections. These patients received a lower
amount of resuscitation fluids and dose of antibiotics
per kilogram. Similarly to the previous study, obese and
very obese patients had significantly lower mortality
compared with normal-weight patients. However, this
‘obesity paradox’ may be explained in part by differences
in baseline characteristics and sepsis interventions, es-
pecially the volume in resuscitation. Indeed, very obese
patients with septic shock had fewer hemodynamic dis-
turbances and required lower doses of vasopressorsthan normal-weight patients, though with comparable
APACHE II scores.
Enteral nutrition and gastrointestinal disorders
Early versus late enteral nutrition
Compared with parenteral nutrition support, the introduc-
tion of early enteral nutrition within the first 24 to 48 hours
after ICU admission has been associated with positive ef-
fects: less septic complications, better course of primary
disease, and shorter stay in the ICU [23]. These findings
were attributed to the prevention of worsening in intestinal
permeability, interruption of the catabolic process, and res-
toration of the immune response. Incretin hormones, like
glucagon-like-peptide-1 (GLP-1) and gastric inhibitory
polypeptide, originate from the gastrointestinal system in
response to the presence of nutrition in the intestinal
lumen and potentiate postprandial insulin secretion. GLP-1
is secreted principally from the L cells of the distal ileum.
In a recent study, GLP-1 was shown to act as an immune
modulator and influence cell-mediated immunity [24]. The
impacts of early enteral nutrition and late enteral nutrition
(beginning 48 hours after admission) on plasma GLP-1
levels of 20 ICU patients with thromboembolic stroke were
determined in a clinical trial [25]. Daily caloric requirement
was determined as 25 kcal/kg per day for each patient ac-
cording to the European Society of Parenteral and Enteral
Nutrition [26]. No significant difference in pre-/post-feed-
ing GLP-1 levels was observed between groups. However,
early enteral nutrition was significantly associated with in-
creased numbers of T helper and regulatory T cells and de-
creased amounts of T cytotoxic cells without any change in
plasma GLP-1, suggesting enteral nutrition-induced effects
on the phenotype of lymphocytes.
Feeding routes
Previous studies demonstrated that early enteral nutrition
reduces the risk of infections when compared with paren-
teral nutrition [27]. Whether the feeding tubes should be
preferentially placed into the stomach or small bowel
remains contentious. Nasogastric tubes are relatively easy
to insert. However, the disadvantage of the intragastric
approach includes delayed gastric emptying and predis-
poses to inadequate nutrient administration. Small bowel
feeding tubes are more difficult to insert, often requiring
specific expertise and equipment. Their potential advan-
tages include bypassing the stomach, which should theor-
etically guarantee delivery of nutrients. In fact, the major
gastrointestinal motility disorders in the critically ill ap-
pear to occur in the antral-pyloro region of the stomach.
A further consideration is that the delivery of nutrients
into the small bowel does imply an intact absorption of
nutrients.
Over the past decade, four systematic reviews were
published about the risk of pneumonia with gastric or
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results. Two suggested that small bowel feeding reduces
the risk of pneumonia [28,29], whereas the other two
did not [30,31]. These conflicting results could be re-
lated to differences in search strategies, type of patients
included, management of gastric emptying, or outcome
definition. A new systematic review and meta-analysis
including 19 trials (n =1,394 patients) tried to determine
the effect of small bowel feeding compared with gastric
feeding on the frequency of pneumonia [32]. The results
showed that small bowel feeding in comparison with
gastric feeding reduces the risk of pneumonia in critic-
ally ill patients, but no difference was seen in mortality,
length of ICU stay, or duration of mechanical ventila-
tion. The mechanism by which small bowel feeding
could reduce pneumonia is not entirely clear. It has been
presumed that increased gastric volume leads to regurgi-
tation and aspiration, yet multiple studies failed to dem-
onstrate an association between elevated gastric residual
volume and risk of aspiration [33]. A second systematic
review of the same topic was published last year [34]. All
randomized controlled studies published between 1990
and 2013 were included. As in the previous study, small
bowel feeding was associated with a reduced risk of
pneumonia. Duration of ventilation and mortality were
also unaffected by the route of feeding.
As recommended by current guidelines [35], nutritional
support using enteral nutrition should be the preferred
method in patients with severe acute pancreatitis. A meta-
analysis, which aimed to determine an ideal nutrient feed-
ing approach, included three randomized controlled trials
(n =157 patients) comparing nasogastric and nasojejunal
feeding in patients with predicted severe acute pancreatitis
[36]. No significant differences were observed between the
two groups in the incidence of mortality, tracheal aspir-
ation, or exacerbation of pain. Also, the achievement of
energy balance was not different, suggesting that nasogas-
tric feeding is safe and well tolerated compared with naso-
jejunal feeding. All together, patients with relatively
‘normal’ gastric emptying and esophago-gastric motility
are unlikely to benefit from small intestinal feeding.
Assessment of whole-body protein turnover
The measurement of protein turnover, including the rate
of protein synthesis and degradation, is challenging during
critical illness. A pilot study included 16 neurosurgical pa-
tients to evaluate the effect of low and high caloric intake
on whole-body protein turnover assessed by radiolabeled
leucine and phenylalanine [37]. Overall, low caloric intake
was associated with a more negative protein balance com-
pared with high caloric intake. However, the rate of oxida-
tion of amino acids was unchanged by the caloric load.
This study demonstrates that a sophisticated assessment
of whole-body protein turnover is feasible and helpful toimprove the understanding of the metabolic response to
stress of critically ill patients.
Diarrhea
Conflicting results were obtained from previous trials
about the impact of enteral nutrition on the occurrence of
diarrhea. Some authors argued that enteral nutrition
reduces the incidence of diarrhea through a better preser-
vation of intestinal mucosa, whereas others found a posi-
tive relation between enteral nutrition and diarrhea [38].
The incidence and risk factors for diarrhea during the 14
first days of ICU stay were determined in a prospective
observational study (n =278 patients) in a tertiary ICU
population [39]. Diarrhea was observed in 38 patients
(14%). Clostridium difficile infection is always suspected
when diarrhea occurs in the ICU, mainly in patients with
antibiotics, but a low incidence of C. difficile was observed
(0.7%), which is in accordance with previous studies [40].
The presence of enteral nutrition per se had no impact on
the risk of diarrhea. However, enteral nutrition, when de-
livering more than 60% of the energy target, increased the
risk of diarrhea (relative risk =1.75). The other factors sig-
nificantly and independently associated with the risk of
diarrhea were antibiotics (relative risk =3.64) and antifungal
drugs (relative risk =2.79). Furthermore, when combined,
these negative effects were additive. These results suggest
that enteral nutrition, even if covering the energy target,
should not be incriminated as the sole cause of diarrhea in
ICU. Because other factors could increase the diarrhea risk,
diarrhea onset in ICU patients receiving enteral nutrition
must not be systematically considered a non-functionality
of the gastrointestinal tract and should not lead to system-
atic discontinuation of enteral nutrition. Otherwise, if en-
teral nutrition is considered the primary cause of diarrhea,
changes in the administration flow rate or replacement of
the enteral nutrition solution can be considered.
Experimental studies
Three animal studies that focused on different topics were
published last year. The first study evaluated the two
major components that accompany severe trauma: a
period of hypermetabolism and disuse [41]. These two
combined components contribute to a multitude of issues
limiting or prolonging (or both) recovery from injury.
Therefore, a rat model combining immobilization and se-
vere burn was used to determine the effects of burn and
disuse, independently and in combination, on body com-
position, food intake, and adipokines (leptin, resistin, and
adiponectin) that have been associated with the inflamma-
tory response to injury, insulin resistance, and the severity
of illness [42,43]. The results of the study showed that, in-
dependently, burn injury and disuse have similar body
mass reductions from control. However, when combined,
additive effects were apparent. Reduced adipokine levels
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suggesting a greater influence of the injury component.
Furthermore, the observed changes in adipokines provide
insight for intervention to attenuate the hypermetabolic
state following injury.
The second study assessed, in an ovine model, the im-
pact of lactic acid infusion on whole-body CO2 production
compared with an isocaloric glucose infusion [44]. In case
of partial extracorporeal CO2 removal, the rate of CO2 re-
moval is limited by the fact that most of the CO2 in blood
is present as bicarbonate ion that cannot cross the artifi-
cial lung membrane. In those circumstances, infusion of
lactic acid may be beneficial [45]. Indeed, acid infusion
shifts bicarbonate dissociation to the gaseous CO2 form,
increasing the transmembrane pressure gradient and thus
increasing extracorporeal CO2 removal. However, lactic
acid metabolism might increase total body CO2 produc-
tion, limiting the potential beneficial effects of this tech-
nique. A slight increase in CO2 production (less than 5%)
was observed after the administration of 50% of the total
caloric input with an infusion of lactic acid compared with
an equal caloric load provided entirely by infusion of 50%
glucose solution. Blood acidification at the inlet of a mem-
brane lung therefore should be considered a promising
technique to reduce the ventilator needs.
Conclusions
The areas of critical illness-associated metabolic and
endocrine alterations received increasingly large attention
reflected by the articles published in 2013. The issues of
stress hyperglycemia and glucose control, including on-
line/continuous glucose measurement techniques, were
further investigated. The ‘obesity paradox’ phenomenon
has been a particularly hot topic. The nutritional aspects
of critical illness draw attention to the benefits of early en-
teral nutrition, especially its immune consequences. All
together, new fields of research were opened by the high-
quality articles published in Critical Care in 2013.Note: This article is part of a collection of Year in review
articles in Critical Care. Other articles in this series can be
found at [46].Abbreviations
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